Comparison of protective effect of protein and DNA vaccines hsp90 in murine model of systemic candidiasis

Folia Microbiologica

Volumn 50, Issue 1, 2005, Pages 77-82

  Raska M ^a,b   Belakova J ^a   Wudattu, N K ^a   Kafkova L ^a   Ruzickova K ^a   Sebestova M ^a   Kolar Z ^a   Weigl, E ^a  

^a PALACKÝ UNIVERSITY   (Czech Republic)

^b University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANDIDA ALBICANS; MURINAE;

EID: 19444374263     PISSN: 00155632     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02931297     Document Type: Article

References (19)

1. BOCCHIA M., BRONTE V., COLOMBO M.P., DE VINCENTIIS A., DI NICOLA M., FORNI G., LANATA L., LEMOLI R.M., MASSAIA M., RONDELLI D., ZANON P., TURA S.: Antitumor vaccination: where we stand. Haematologica 85, 1172-1206 (2000).
2. BURNIE J., MATTHEWS R.: Genetically recombinant antibodies: new therapeutics against candidiasis. Expert Opin.Biol.Ther. 4, 233-241 (2004).
3. BYSTRICKÝ S., PAULOVIČOVÁ E., MACHOVÁ E.: Candida albicans mannan-protein conjugate as vaccine candidate. Immunol.Lett. 85, 251-255 (2003).
4. CASSONE A., CONTI S., DEBERNADIS F., POLONELLI L.: Antibodies, killer toxins and antifungal immunoprotection: a lesson from nature? Immunol.Today 18, 164-169 (1997).
5. CHOMCZYNSKI P., SACCHI N.: Single-step method of RNA isolation by acid guanidine thiocyanate-phenol-chloroform extraction. Anal.Biochem. 162, 156-159 (1987).
6. DE BERNARDIS F., SULLIVAN P.A., CASSONE A.: Aspartyl proteinases of Candida albicans and their role in pathogenicity. Med.Mycol. 39, 303-313 (2001).
7. DONNELLY J.J., ULMER J.B., SHIVER J.W., LIU M.A.: DNA vaccines. Ann.Rev.Immunol. 15, 617-648 (1997).
8. DORKO E., VIRÁGOVÁ S., PILIPČINEC E., TKÁČIKOVÁ L.: Detection of anti-Candida antibodies in neonates from a Neonatal Intensive Care Unit. Folia Microbiol. 47, 297-301 (2002).
9. GASTON J.S.H.: Heat shock proteins and arthritis - new readers start here. Autoimmuity 26, 33-42 (1997).
10. HAN Y., ULRICH M.A., CUTLER J.E.: Candida albicans mannan extract-protein conjugates induce a protective immune response against experimental candidiasis. J.Infect.Dis. 179, 1477-1484 (1999).
11. KOZAK M.: An analysis of vertebrate mRNA sequences: intimations of translational control. J.Cell.Biol. 115, 887-903 (1991).
12. MATTHEWS R.C., HODGETTS S., BURNIE J.P.: Preliminary assessment of a human recombinant antibody fragment to hsp90 in murine invasive candidiasis. J.Infect.Dis. 171, 1668-1671 (1995).
13. PEACHMAN K.K., RAO M., ALVING C.R.: Immunization with DNA through the skin. Methods 31, 232-242 (2003).
14. POULAIN D., SLOMIANNY C., JOUAULT T., GOMEZ J.M., TRINEL P.A.: Contribution of phospholipomannan to the surface expression of β-1,2-oligomannosides in Candida albicans and its presence in cell wall extracts. Infect.Immun. 70, 4323-4328 (2002).
15. ROMANI L.: Innate and adaptive immunity in Candida albicans infections and saprophytism. J.Leukoc.Biol. 68, 175-179 (2000).
16. SAMBROOK J., FRITSCH E.F., MANIATIS T.: Plasmid vectors, pp. 1.53-1.104 in C. Nolan, M. Ferguson (Eds): Molecular Cloning: a Laboratory Manual. Cold Spring Harbor Laboratory Press, New York 1989.
17. TOMŠÍKOVÁ A.: Causative agents of nosocomial mycoses. Folia Microbiol. 47, 105-112 (2002).
18. WEIGL E., KOPEČEK P., RAŠKA M., HRADILOVÁ Š.: Heat shock proteins in immune reactions. Folia Microbiol. 44, 561-566 (1999).
19. ZÜGEL U., SCHOEL B., YAMAMOTO S., HENGEL H., MOREIN B., KAUFMANN S.H.E.: Cross-recognition by CD8 TCR A/B CTL of peptides in the self and the mycobacterial hsp60 which share intermediate sequence homology. Eur.J.Immunol. 25, 451-458 (1995).